Credit Ratings
Credit Rating
Zydus Lifesciences LimitedZYDUSLIFE · Filed with the exchange
CRISIL Ratings has reaffirmed Zydus Lifesciences' credit ratings across its bank facilities (Rs. 4,724 Cr), Commercial Papers (Rs. 200 Cr), and Non-Convertible Debentures (Rs. 125 Cr). The long-term rating stands at CRISIL AAA with a Stable outlook, while the short-term rating is CRISIL A1+. This top-tier rating reflects the company's robust financial health and strong credit profile.
No comments yet. Be the first.